Metabolism of vitamin D3 in human osteoblasts:: Evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D3

被引:191
|
作者
Atkins, Gerald J.
Anderson, Paul H.
Findlay, David M.
Welldon, Katie J.
Vincent, Cristina
Zannettino, Andrew C. W.
O'Loughlin, Peter D.
Morris, Howard A.
机构
[1] Univ Adelaide, Dept Orthopaed & Trauma, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Inst Med & Vet Sci, Div Haematol, Adelaide, SA 5000, Australia
[3] Hanson Inst, Adelaide, SA 5000, Australia
基金
英国医学研究理事会;
关键词
vitamin D; 25-hydroxyvitamin D-3; CYP24; CYP27B1; osteoblasts;
D O I
10.1016/j.bone.2007.02.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Circulating 1 alpha,25-dihydroxyvitamin D-3 (1,25D) derives from renal conversion of 25-hydroxyvitamin D-3 (25D), by the 25D 1 alpha-hydroxylase (CYP27B1). Blood 25D levels, but not 1,25D levels, are the best indicator of vitamin D status and predict fracture risk in the elderly. We examined the extent to which osteoblasts can metabolize 25D. Well-characterized human primary osteoblasts and osteosarcoma (OS) cell lines were examined for the expression and regulation of genes associated with vitamin D metabolism, using real-time PCR. Primary osteoblasts and OS cell lines were found to express CYP27B1 mRNA and secreted detectable 1,25D in response to 25D. Of the OS cell lines tested, HOS expressed the most CYP27B1 mRNA and secreted the highest levels of 1,25D. All osteoblastic cells examined up-regulated expression of the catabolic regulator of 1,25D, the 25-hydroxyvitamin D-24-hydroxylase (CYP24), when incubated with either 1,25D or 25D. Exposure to physiological levels of 25D resulted in up-regulated transcription of the 1,25D responsive genes, osteocalcin (OCN), osteopontin (OPN) and RANKL. Specific knockdown of CYP27B1 in HOS cells using siRNA resulted in up to 80% reduction in both 1,25D secretion and the transcription of OCN and CYP24, strongly implying that the 25D effect in osteoblasts is preceded by conversion to 1,25D. Incubation with 25D, like 1,251), inhibited primary osteoblast proliferation and promoted in vitro mineralization. Finally, we detected expression by osteoblasts of receptors for vitamin D binding protein (DBP), cubilin and megalin, suggesting that osteoblasts are able to internalize DBP-25D complexes in vivo. Together, our results suggest that autocrine, and perhaps paracrine, pathways of vitamin D-3 metabolism may regulate key osteoblast functions independently of circulating, kidney derived 1,25D. Our results are therefore consistent with the reported benefits of maintaining a healthy vitamin D status in the elderly to reduce the risk of fractures. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1517 / 1528
页数:12
相关论文
共 50 条
  • [21] The ratio of serum 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 is predictive of 25-hydroxyvitamin D3 response to vitamin D3 supplementation
    Wagner, Dennis
    Hanwell, Heather E.
    Schnabl, Kareena
    Yazdanpanah, Mehrdad
    Kimball, Samantha
    Fu, Lei
    Sidhom, Gloria
    Rousseau, Derick
    Cole, David E. C.
    Vieth, Reinhold
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2011, 126 (3-5): : 72 - 77
  • [22] Evidence that both 1α,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization
    van Driel, M.
    Koedam, M.
    Buurman, C. J.
    Roelse, M.
    Weyts, F.
    Chiba, H.
    Uitterlinden, A. G.
    Pols, H. A. P.
    Van Leeuwen, J. P. T. M.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 99 (03) : 922 - 935
  • [23] Characterization of 3-epi-1α,25-dihydroxyvitamin D3 involved in 1α,25-dihydroxyvitamin D3 metabolic pathway in cultured cell lines
    Masuda, S
    Kamao, M
    Schroeder, NJ
    Makin, HLJ
    Jones, G
    Kremer, R
    Rhim, J
    Okano, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (02) : 133 - 139
  • [24] Metabolism of 2α-propoxy-1α,25-dihydroxyvitamin D3 and 2α-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 by human CYP27A1 and CYP24A1
    Abe, D
    Sakaki, T
    Kusudo, T
    Kittaka, A
    Saito, N
    Suhara, Y
    Fujishima, T
    Takayama, H
    Hamamoto, H
    Kamakura, M
    Ohta, M
    Inouye, K
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (06) : 778 - 784
  • [25] Serum Concentrations of 1,25-Dihydroxyvitamin D2 and 1,25-Dihydroxyvitamin D3 in Response to Vitamin D2 and Vitamin D3 Supplementation
    Biancuzzo, Rachael M.
    Clarke, Nigel
    Reitz, Richard E.
    Travison, Thomas G.
    Holick, Michael F.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (03): : 973 - 979
  • [26] Optimization of culture conditions for the bioconversion of vitamin D3 to 1α,25-dihydroxyvitamin D3 usingPseudonocardia autotrophica ID 9302
    Dae-Jung Kang
    Hong-Sub Lee
    Joon-Tae Park
    Ji Sun Bang
    Soon-Kwang Hong
    Tae-Yong Kim
    Biotechnology and Bioprocess Engineering, 2006, 11 : 408 - 413
  • [27] 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 Promote the Differentiation of Human Subcutaneous Preadipocytes
    Nimitphong, Hataikarn
    Holick, Michael F.
    Fried, Susan K.
    Lee, Mi-Jeong
    PLOS ONE, 2012, 7 (12):
  • [28] Selective analogs of 1α,25-dihydroxyvitamin D3 for the study of specific functions of Vitamin D
    DeLuca, Hector F.
    Plum, Lori A.
    Clagett-Dame, Margaret
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5): : 263 - 268
  • [29] 1α,25-dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action
    Shi, H
    Norman, AW
    Okamura, WH
    Sen, A
    Zemel, MB
    FASEB JOURNAL, 2001, 15 (12): : 2751 - +
  • [30] Human neutrophils express messenger RNA of vitamin D receptor and respond to 1α,25-dihydroxyvitamin D3
    Takahashi, K
    Nakayama, Y
    Horiuchi, H
    Ohta, T
    Komoriya, K
    Ohmori, H
    Kamimura, T
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2002, 24 (03) : 335 - 347